NephroDI Therapeutics Announces Investment by Sound Bioventures to Accelerate Development of NDI-5001 as a Potential First-in-Class Therapy for Pediatric Orphan Kidney Disease
20 juin 2024 07h00 HE
|
NephroDI Therapeutics
New funding to take NDI-5001 into and through clinical proof of concept in Congenital Nephrogenic Diabetes Insipidus (NDI)New investment complements previously announced strategic corporate...
Sound Bioventures expands portfolio with new investment in US company NephroDI Therapeutics to accelerate development of NDI-5001 for pediatric orphan kidney disease
20 juin 2024 07h00 HE
|
Sound Bioventures
New funding will accelerate NephroDI’s asset, NDI-5001, into and through clinical proof of concept in Congenital Nephrogenic Diabetes Insipidus (NDI)New investment complements NephroDI’s previously...
Pediatric Electronic Medical Record (EMR) Software Market Analysis, 2018-2023 and 2024-2033 - Meta Platforms, Oracle, SAP, Cognizant Technology Solutions, and Koninklijke Philips Dominate the $3.83Bn Market
06 mai 2024 04h16 HE
|
Research and Markets
Dublin, May 06, 2024 (GLOBE NEWSWIRE) -- The "Pediatric Electronic Medical Record (EMR) Software Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global...
CareFirst BlueCross BlueShield and Children’s National Hospital Expand Access to Mental Health and Chronic Condition Support for Kids
01 mai 2024 13h01 HE
|
Children's National Hospital
Washington D.C., May 01, 2024 (GLOBE NEWSWIRE) -- Today, CareFirst BlueCross BlueShield (CareFirst), one of the largest not-for-profit healthcare organizations in the nation, and Children’s National...
Infectious Disease Connect Expands Telemedicine Services
16 avr. 2024 09h15 HE
|
Infectious Disease Connect
PITTSBURGH, April 16, 2024 (GLOBE NEWSWIRE) -- Infectious Disease Connect (ID Connect), a leading infectious diseases telemedicine and software solutions company, has expanded its services to meet...
Sequel’s twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance
18 mars 2024 07h05 HE
|
Sequel Med Tech
Sequel’s twiist™ automated insulin delivery system receives FDA 510(k) clearance. Significant advancements for people with people with Type 1 diabetes.
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)
13 mars 2024 07h55 HE
|
Catalyst Pharmaceuticals, Inc.
AGAMREE® (vamorolone) a Novel Alternative Corticosteroid with Demonstrated Properties in Maintaining Efficacy and a Well-Tolerated Side Effect Profile Available in the U.S. by Prescription for...
Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and Vaccines
12 mars 2024 08h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, March 12, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that the United States Patent and Trademark Office...
Evolving pediatric care needs in community-based settings
30 janv. 2024 08h49 HE
|
WellSpan Health
York, Pa., Jan. 30, 2024 (GLOBE NEWSWIRE) -- WellSpan’s longstanding commitment to providing quality children’s health care is at the core of our mission and stretches across all communities we...
Analysis of Global Pediatric Neuroblastoma Treatment Markets, 2018-2033: Unveiling Trends in Emerging Therapies, Personalized Medicine, Access to Treatment, and Patient Advocacy & Support
18 janv. 2024 05h33 HE
|
Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Pediatric Neuroblastoma Treatment Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global pediatric...